Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2019 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value
Symbol
CRBP on Nasdaq
Shares outstanding
17,685,185
Price per share
$8.66
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
13,187,549
Total reported value
$107,347,831
% of total 13F portfolios
0%
Share change
+4,456,167
Value change
+$34,670,749
Number of holders
99
Price from insider filings
$8.66
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cormorant Asset Management, LP 13% +4.2% $24,434,598 -$312,902 2,344,971 -1.3% Cormorant Asset Management, LP 11 Dec 2025
Aberdeen Group plc 7.5% $10,759,045 1,321,750 Aberdeen Group plc 31 Dec 2025
CITADEL ADVISORS LLC 5.3% $12,405,011 980,610 Kenneth Griffin 04 Nov 2025
Octagon Capital Advisors LP 5.4% $7,582,700 955,000 Octagon Capital Advisors LP 31 Dec 2025
ORBIMED ADVISORS LLC 5.9% $5,307,498 718,200 OrbiMed Capital LLC 31 Dec 2024
VANGUARD GROUP INC 4.9% $4,136,516 599,495 The Vanguard Group 30 Jun 2025
BlackRock, Inc. 2.9% $2,431,622 352,409 BlackRock, Inc. 30 Jun 2025

As of 31 Dec 2025, 99 institutional investors reported holding 13,187,549 shares of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP). This represents 75% of the company’s total 17,685,185 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) together control 69% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Cormorant Asset Management, LP 13% 2,344,971 -1.3% 1.1% $19,088,064
ORBIMED ADVISORS LLC 9% 1,597,287 +36% 0.28% $13,001,916
Aberdeen Group plc 7.5% 1,321,750 +602% 0.02% $10,759,045
Octagon Capital Advisors LP 5.4% 955,000 -14% 0.97% $7,773,700
VANGUARD GROUP INC 4.9% 859,407 +40% 0% $6,995,573
CITADEL ADVISORS LLC 4.8% 843,193 0% $6,863,591
Prosight Management, LP 3.9% 683,872 +99% 1.2% $5,566,718
ARMISTICE CAPITAL, LLC 3% 536,000 +179% 0.11% $4,363,040
Stonepine Capital Management, LLC 2.2% 389,916 2.5% $3,173,916
RENAISSANCE TECHNOLOGIES LLC 2% 354,300 +231% 0% $2,884,002
ADAR1 Capital Management, LLC 1.6% 286,781 +2712% 0.17% $2,334,397
BlackRock, Inc. 1.5% 268,046 +18% 0% $2,181,894
SUSQUEHANNA INTERNATIONAL GROUP, LLP 1.3% 227,826 +229% 0% $1,854,504
COMERICA BANK 1.1% 200,001 0% 0.01% $1,628,008
Assenagon Asset Management S.A. 1.1% 187,956 +120% 0% $1,529,962
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 1% 182,062 +112% 0% $1,481,985
GEODE CAPITAL MANAGEMENT, LLC 0.97% 170,873 +34% 0% $1,391,329
Exome Asset Management LLC 0.79% 139,543 -39% 0.58% $1,135,880
AMERIPRISE FINANCIAL INC 0.77% 135,730 +95% 0% $1,104,842
Balyasny Asset Management L.P. 0.75% 133,311 +469% 0% $1,085,152
Atle Fund Management AB 0.61% 107,255 0% 0.28% $873,055
683 Capital Management, LLC 0.48% 85,543 0.06% $696,320
MARSHALL WACE, LLP 0.44% 77,546 -24% 0% $631,226
DIMENSIONAL FUND ADVISORS LP 0.44% 77,354 0% $629,661
Point72 Asset Management, L.P. 0.42% 75,134 0% $611,591

Institutional Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 13,187,549 $107,347,831 +$34,670,749 $8.14 99
2025 Q3 8,624,602 $109,102,095 -$2,067,263 $12.65 79
2025 Q2 9,061,852 $62,525,276 -$8,932,514 $6.90 78
2025 Q1 10,430,351 $55,391,632 -$13,394,437 $5.31 85
2024 Q4 10,952,105 $129,272,235 -$16,308,014 $11.80 98
2024 Q3 11,745,584 $242,331,671 -$44,650,435 $20.63 106
2024 Q2 10,752,925 $486,116,698 +$101,256,908 $45.25 107
2024 Q1 8,529,313 $334,743,519 +$310,281,997 $39.24 81
2023 Q4 749,666 $4,528,896 +$40,967 $6.04 32
2023 Q3 742,967 $5,007,338 +$30,936 $6.74 26
2023 Q2 739,439 $5,797,676 +$132,453 $7.84 28
2023 Q1 723,148 $5,257,408 +$5,257,398 $7.27 28
2020 Q2 0 $0 -$5,240 $8.66 0
2020 Q1 1,000 $5,240 $5.24 1
2019 Q4 1,000 $5,460 $5.46 1